L-Serine ( DrugBank: Serine, L-Serine )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
2	Amyotrophic lateral sclerosis	2

2. Amyotrophic lateral sclerosis

---

Clinical trials : 645 /  Drugs : 589 - (DrugBank : 163) / Drug target genes : 150 - Drug target pathways : 225

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03580616 (ClinicalTrials.gov)	October 24, 2018	26/6/2018	Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)	Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Study	Amyotrophic Lateral Sclerosis (ALS)	Drug: L-Serine	Elijah W. Stommel	Brain Chemistry Labs, Institute for Ethnomedicine	Suspended	18 Years	N/A	All	50	Phase 2	United States
2	NCT01835782 (ClinicalTrials.gov)	January 2013	27/3/2013	Determining the Safety of L-serine in ALS	Determining the Safety of L-Serine in Subjects With Amyotrophic Lateral Sclerois (ALS) at Varied Doses.	Amyotrophic Lateral Sclerosis (ALS)	Drug: L-Serine	Phoenix Neurological Associates, LTD	Institute for Ethnomedicine	Active, not recruiting	18 Years	85 Years	Both	20	Phase 1/Phase 2	United States